The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report
Timestops (2)
Tools Used
Topic Overview
Key Takeaways
- IDRFs are imaging findings on CT/MRI that predict when neuroblastoma surgery may be difficult or dangerous to perform safely.
- The INRG defined 20 specific image-defined risk factors in 2009, most relating to tumor interaction with critical anatomical structures.
- Abdominal tumors infiltrating the portahepati or hepatoduodenal ligament are considered to contain IDRFs.
- Presence of IDRFs signals technically complex surgery; patients often receive neoadjuvant therapy first to shrink the tumor.
- IDRFs help surgeons use imaging to predict surgical risk and guide the safest treatment approach for neuroblastoma patients.
Keywords
Hashtags
Transcript
If you're someone who treats neuroblastoma, you need to know about IDRFs to know whether it's safe to go to the operating room. Hi, I'm Dr. Sophia Skermhorn, a research fellow at Cincinnati Children's, and today I'm going to explain image-defined risk factors, also known as IDRFs. IDRFs are imaging findings on CT or MRIs that predict when a neuroblastoma may be difficult or dangerous to remove surgically. The concept was first introduced in 2009 by the International Neuroblastoma Risk Group, which defined 20 specific imaging risk factors shown. Here, most IDRFs relate to how the tumor interacts with critical anatomy. For example, in the abdomen, a tumor that infiltrates the portahepati or hepatoduodenal ligament would be considered to contain an IDRF. The presence of an IDRF doesn't mean that a tumor can't be resected, but it does signal that the surgery may be technically more complex, and patients often receive neoadjuvant therapy first to try to shrink the tumor. So when surgeons talk about IDRFs, what they're really doing is using imaging to predict surgical risk and guide the safest treatment approach.